Patent details

Basic Information

Publication number:

EP2863941

PCT Application Number:

US2013028608

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137554663

PCT Publication Number:

WO2013130963

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

VELAGLUCERASE FOR TREATING TYPE III GAUCHER DISEASE

French Title of Invention:

VÉLAGLUCÉRASE POUR LE TRAITEMENT DE LA MALADIE DE GAUCHER DE TYPE III

German Title of Invention:

VELAGLUCERASE ZUR BEHANDLUNG VON MORBUS GAUCHER TYP III

SPC Number:

Dates

Filing date:

01/03/2013

Grant date:

19/12/2018

EP Publication Date:

29/04/2015

PCT Publication Date:

06/09/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/12/2018

EP B1 Publication Date:

19/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/03/2019

Expiration date:

01/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2018

 

 

Name:

Shire Human Genetic Therapies, Inc.

Address:

300 Shire Way, Lexington MA 02421, United States (US)

Inventor

1

Name:

BHIRANGI, Kiran

Address:

United States (US)

2

Name:

COHN, Gabriel, Martin

Address:

United States (US)

3

Name:

CROMBEZ, Eric

Address:

United States (US)

Priority

Priority Number:

201261606089 P

Priority Date:

02/03/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 38/47; A61P 3/00; A61P 43/00; G01N 33/538; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

201851

Publication date:

19/12/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages